Dosing has begun in a new regimen of the HEALEY ALS platform trial, its ninth, which is testing the oral therapy NUZ-001 for use in ALS.

Being diagnosed with ALS has changed many of the assumptions that columnist Justin Ramirez had about fatherhood, but he still remains "Dad." ...

Blood lactate levels were associated with survival and weight changes in ALS, according to a study in Australia and Japan.

AB Science says a newly identified blood biomarker may help assess masitinib activity in its ongoing Phase 3 ALS clinical ...

Next week, researchers, clinicians, industry leaders, and families will gather at the 2026 MDA Clinical & Scientific Conference, hosted by the Muscular Dystrophy Association (MDA), to discuss the ...

Rather than worrying about bucket list adventures, columnist Juliet Taylor and her late husband, Jeff, focused on friends and ...

Early birds are at a significantly lower risk of developing amyotrophic lateral sclerosis (ALS) than night owls, according to a new study.

Columnist Kristin Neva finds herself unable to sleep one night as she mulls over her husband's ALS disease progression.

QRL-201 shows potential to slow ALS progression by restoring a key protein needed for nerve health, according to data from a Phase 1/2 trial.

The MDA Shamrocks campaign raises funds to support people living with ALS and other rare neuromuscular diseases. Funds support research, high-quality care, educational programs, and advocacy efforts ...

I have to confess: I envy people who multitask. It is something I used to do with ease, but ALS has firmly put those days in the rearview mirror. It’s not even that I am “tasking” much these days; I ...